Sentence examples for molecular test of from inspiring English sources

However, the XDR-TB studies that reported very high PZA resistance were all based on molecular test of pncA sequencing rather than conventional PZA susceptibility testing.

Homozygosity of this strain for resistant alleles at the Kdr and ace-1 loci was achieved by the F3 generation, as confirmed by the molecular test of Martinez-Torres et al. [ 42] and Weill et al. [ 17], respectively.

Finally, homozygosity of the strains for these resistance alleles was verified by analysing parents using the molecular test of Weill et al.. [ 17] BCSR was derived from the cross between SR and BC strains.

The UKALL2003 trial was a prospective randomised trial investigating if treatment allocation, determined by standardised disease indicators (white cell count and age) plus a molecular test of response to early treatment (minimal residual disease: MRD) could increase survival and minimise toxicity in children with ALL.

Of course, if the familial mutation is known, presumably from molecular testing of an affected family member, the carrier status of III-2 could be determined directly by molecular analysis, rather than estimated by Bayesian calculation.

As fungi are often ignored as a source of disease, it is time to add routine molecular testing of fungal pathogens to quality control measures for pharmaceuticals so we can end unnecessary illnesses.

However, accurate molecular testing of PMS2 is complicated by a large number of highly homologous sequences.

This study presents the kinetic, equilibrium, and thermodynamic analyses of DNA hybridization in a microarray system designed for fast molecular testing of pathogenic bacteria.

To critically evaluate our experience in molecular testing of Leber congenital amaurosis (LCA) and to use this information to devise a general approach to heterogeneous recessive disorders.

In 2013, the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for molecular Pathology established guidelines for the molecular testing of all advanced stage lung adenocarcinomas for EGFR mutations and ALK rearrangements prior to treatment [68].

Our step-wise approach allows prioritization of markers if the amount of tissue or resources is limited, in order to optimally conserve tissue for future molecular testing of the lung carcinoma.